Nucleic acid binding, RNA-binding 42 (RNA-binding motif 42) Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 4 |
Pissara et al. | yes | yes: 12 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005829 | cytosol | 2 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:1990904 | ribonucleoprotein complex | 2 | 1 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pescher et al. (upgregulation) | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: A4I5Z0
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003723 | RNA binding | 4 | 1 |
GO:0003729 | mRNA binding | 5 | 1 |
GO:0005488 | binding | 1 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 248 | 250 | PF00675 | 0.701 |
CLV_PCSK_KEX2_1 | 242 | 244 | PF00082 | 0.713 |
CLV_PCSK_PC1ET2_1 | 242 | 244 | PF00082 | 0.713 |
CLV_PCSK_SKI1_1 | 18 | 22 | PF00082 | 0.458 |
CLV_PCSK_SKI1_1 | 258 | 262 | PF00082 | 0.414 |
CLV_PCSK_SKI1_1 | 273 | 277 | PF00082 | 0.432 |
CLV_PCSK_SKI1_1 | 32 | 36 | PF00082 | 0.446 |
DEG_APCC_DBOX_1 | 272 | 280 | PF00400 | 0.511 |
DEG_SCF_FBW7_2 | 150 | 155 | PF00400 | 0.742 |
DOC_MAPK_MEF2A_6 | 311 | 318 | PF00069 | 0.345 |
DOC_PP1_RVXF_1 | 256 | 262 | PF00149 | 0.424 |
DOC_PP2B_PxIxI_1 | 313 | 319 | PF00149 | 0.347 |
DOC_USP7_MATH_1 | 144 | 148 | PF00917 | 0.731 |
DOC_USP7_MATH_1 | 191 | 195 | PF00917 | 0.630 |
DOC_WW_Pin1_4 | 128 | 133 | PF00397 | 0.548 |
DOC_WW_Pin1_4 | 137 | 142 | PF00397 | 0.542 |
DOC_WW_Pin1_4 | 146 | 151 | PF00397 | 0.713 |
LIG_14-3-3_CanoR_1 | 287 | 296 | PF00244 | 0.415 |
LIG_14-3-3_CanoR_1 | 32 | 37 | PF00244 | 0.467 |
LIG_APCC_ABBA_1 | 303 | 308 | PF00400 | 0.545 |
LIG_APCC_ABBAyCdc20_2 | 292 | 298 | PF00400 | 0.477 |
LIG_APCC_ABBAyCdc20_2 | 302 | 308 | PF00400 | 0.503 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.491 |
LIG_BIR_III_3 | 1 | 5 | PF00653 | 0.491 |
LIG_FHA_1 | 262 | 268 | PF00498 | 0.591 |
LIG_FHA_1 | 33 | 39 | PF00498 | 0.389 |
LIG_FHA_2 | 101 | 107 | PF00498 | 0.451 |
LIG_FHA_2 | 266 | 272 | PF00498 | 0.477 |
LIG_FHA_2 | 35 | 41 | PF00498 | 0.363 |
LIG_IRF3_LxIS_1 | 41 | 46 | PF10401 | 0.488 |
LIG_LIR_Gen_1 | 198 | 207 | PF02991 | 0.551 |
LIG_LIR_Nem_3 | 198 | 202 | PF02991 | 0.524 |
LIG_LIR_Nem_3 | 50 | 55 | PF02991 | 0.457 |
LIG_Pex14_2 | 11 | 15 | PF04695 | 0.348 |
LIG_SH2_CRK | 80 | 84 | PF00017 | 0.373 |
LIG_SH2_CRK | 99 | 103 | PF00017 | 0.172 |
LIG_SH2_PTP2 | 52 | 55 | PF00017 | 0.515 |
LIG_SH2_SRC | 52 | 55 | PF00017 | 0.515 |
LIG_SH2_STAT5 | 118 | 121 | PF00017 | 0.379 |
LIG_SH2_STAT5 | 52 | 55 | PF00017 | 0.515 |
LIG_SH3_3 | 129 | 135 | PF00018 | 0.591 |
LIG_SH3_3 | 155 | 161 | PF00018 | 0.707 |
LIG_SUMO_SIM_par_1 | 34 | 40 | PF11976 | 0.430 |
LIG_TRAF2_1 | 167 | 170 | PF00917 | 0.760 |
LIG_WRC_WIRS_1 | 105 | 110 | PF05994 | 0.534 |
LIG_WW_3 | 244 | 248 | PF00397 | 0.713 |
MOD_CK1_1 | 198 | 204 | PF00069 | 0.570 |
MOD_CK2_1 | 100 | 106 | PF00069 | 0.453 |
MOD_CK2_1 | 265 | 271 | PF00069 | 0.448 |
MOD_Cter_Amidation | 223 | 226 | PF01082 | 0.768 |
MOD_GlcNHglycan | 172 | 175 | PF01048 | 0.722 |
MOD_GlcNHglycan | 279 | 282 | PF01048 | 0.478 |
MOD_GlcNHglycan | 289 | 292 | PF01048 | 0.341 |
MOD_GSK3_1 | 100 | 107 | PF00069 | 0.455 |
MOD_GSK3_1 | 144 | 151 | PF00069 | 0.682 |
MOD_GSK3_1 | 191 | 198 | PF00069 | 0.578 |
MOD_GSK3_1 | 261 | 268 | PF00069 | 0.536 |
MOD_GSK3_1 | 60 | 67 | PF00069 | 0.469 |
MOD_N-GLC_1 | 261 | 266 | PF02516 | 0.536 |
MOD_N-GLC_1 | 287 | 292 | PF02516 | 0.434 |
MOD_NEK2_1 | 108 | 113 | PF00069 | 0.580 |
MOD_NEK2_1 | 260 | 265 | PF00069 | 0.571 |
MOD_NEK2_1 | 64 | 69 | PF00069 | 0.480 |
MOD_PK_1 | 70 | 76 | PF00069 | 0.477 |
MOD_PKA_1 | 225 | 231 | PF00069 | 0.713 |
MOD_PKA_1 | 249 | 255 | PF00069 | 0.718 |
MOD_PKB_1 | 247 | 255 | PF00069 | 0.726 |
MOD_PKB_1 | 68 | 76 | PF00069 | 0.530 |
MOD_Plk_4 | 198 | 204 | PF00069 | 0.612 |
MOD_Plk_4 | 321 | 327 | PF00069 | 0.461 |
MOD_Plk_4 | 48 | 54 | PF00069 | 0.440 |
MOD_ProDKin_1 | 128 | 134 | PF00069 | 0.558 |
MOD_ProDKin_1 | 137 | 143 | PF00069 | 0.545 |
MOD_ProDKin_1 | 146 | 152 | PF00069 | 0.713 |
MOD_SUMO_for_1 | 163 | 166 | PF00179 | 0.780 |
MOD_SUMO_rev_2 | 179 | 188 | PF00179 | 0.728 |
TRG_ENDOCYTIC_2 | 52 | 55 | PF00928 | 0.515 |
TRG_ENDOCYTIC_2 | 80 | 83 | PF00928 | 0.379 |
TRG_ENDOCYTIC_2 | 98 | 101 | PF00928 | 0.345 |
TRG_ER_diArg_1 | 326 | 329 | PF00400 | 0.485 |
TRG_ER_diArg_1 | 68 | 71 | PF00400 | 0.536 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IL25 | Leptomonas seymouri | 65% | 96% |
A0A3R7N1J6 | Trypanosoma rangeli | 38% | 86% |
A0A3S5H7N8 | Leishmania donovani | 100% | 100% |
A4HIP3 | Leishmania braziliensis | 86% | 100% |
E9B183 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
Q4Q6Y1 | Leishmania major | 93% | 100% |
V5BX42 | Trypanosoma cruzi | 38% | 80% |